"10.1371_journal.pone.0078567","plos one","2013-11-08T00:00:00Z","Nasheeta Peer; Krisela Steyn; Carl Lombard; Nomonde Gwebushe; Naomi Levitt","Chronic Diseases of Lifestyle Unit, Medical Research Council, Durban, South Africa; Chronic Disease Initiative for Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa; Biostatistics Unit, Medical Research Council, Cape Town, South Africa; Division of Endocrinology and Diabetes, Department of Medicine, Cape Town, South Africa","Conceived and designed the experiments: NP KS CL NG NL. Analyzed the data: NP CL NG. Wrote the paper: NP KS CL NL.","Naomi Levitt has received honoraria from Novartis for serving on the steering committee for the Navigator Trial and travel support from Novo Nordisk, Eli Lilly Laboratories and Sanofi Aventis. All other authors report no potential conflicts of interest, including specific financial interests, relevant to the subject of this manuscript. This work was partly supported by an unrestricted grant from Servier Laboratories (South Africa). There are no patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","11","Nasheeta Peer","NP",5,TRUE,5,NA,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
